U.S. Long COVID Brain Fog Far Worse Than in Poorer Nations

Long COVID Neurological Symptoms Differ Greatly by Country Individuals suffering from long COVID in the United States experience significantly elevated levels of brain fog, depression, and cognitive difficulties compared to those in nations like India and Nigeria, as revealed by an extensive interna

Long COVID Neurological Symptoms Differ Greatly by Country

Individuals suffering from long COVID in the United States experience significantly elevated levels of brain fog, depression, and cognitive difficulties compared to those in nations like India and Nigeria, as revealed by an extensive international investigation spearheaded by Northwestern Medicine experts.

Experts emphasize that these disparities do not indicate that Americans endure more intense physical illness. Rather, the elevated reporting of symptoms in the U.S. likely stems from improved availability of neurological and mental health services, coupled with reduced societal stigma associated with openly addressing cognitive and emotional challenges.

Pioneering Cross-Continental Examination of Long COVID Brain Issues

This groundbreaking research marks the inaugural effort to systematically contrast neurological manifestations of long COVID spanning multiple continents. The team tracked over 3,100 adults grappling with long COVID, all assessed at prestigious academic medical facilities located in Chicago, Medellín in Colombia, Lagos in Nigeria, and Jaipur in India.

The majority of these individuals had not required hospitalization during their acute COVID-19 episodes. Among non-hospitalized participants, an astonishing 86% from the U.S. described battling brain fog. In stark contrast, this symptom afflicted 63% in Nigeria, 62% in Colombia, and a mere 15% in India.

Patterns in mental health complaints mirrored these trends closely. Approximately 75% of non-hospitalized U.S. patients indicated struggles with depression or anxiety. That percentage fell to around 40% in Colombia, while under 20% of participants in Nigeria and India noted comparable emotional turmoil.

Cultural Influences on How Symptoms Are Reported

In the U.S. and Colombia, discussing mental health and cognitive impairments is widely socially acceptable, unlike in Nigeria and India, according to Dr. Igor Koralnik, the study's senior author and head of neuro-infectious disease and global neurology at Northwestern University Feinberg School of Medicine.

Cultural reluctance to acknowledge mood-related disorders, alongside factors such as stigma, misunderstandings, religious convictions, entrenched belief systems, and limited health education, can lead to underreporting of symptoms. These issues are further exacerbated by shortages of mental health professionals and a perceived scarcity of viable treatment pathways in those regions.

The findings appeared in Frontiers in Human Neuroscience on January 28.

Prevalent Neurological Complaints in Every Studied Location

Regardless of the country, the most commonly cited neurological issues encompassed brain fog, profound fatigue, myalgia or muscle aches, persistent headaches, sensations of dizziness, and various sensory disruptions like numbness or tingling sensations.

Disruptions in sleep patterns showed considerable variation as well. Close to 60% of non-hospitalized patients from the U.S. complained of insomnia, whereas in Colombia, Nigeria, and India, the rate hovered at about one-third or even lower.

Statistical examination of these symptom profiles revealed a pronounced separation between high-income and upper-middle-income nations like the U.S. and Colombia, on one side, and lower-middle-income countries such as Nigeria and India, on the other.

Details of the Research Methodology

This observational investigation recruited adults persisting with neurological symptoms post-COVID-19 infection from 2020 through 2025. Participants were drawn from four leading academic medical centers, encompassing both those who had been hospitalized and those who had not during their initial illness.

Evaluations relied on uniform protocols for neurological examinations, cognitive testing, and assessments of life quality, implemented consistently at every location to facilitate reliable cross-regional comparisons.

The Worldwide Impact of Long COVID

Long COVID impacts millions globally, characterized by symptoms that linger for weeks, months, or even years following the initial coronavirus infection. Projections indicate that between 10% and 30% of adults who contract COVID-19 go on to develop these protracted effects, with cognitive and neurological disturbances ranking among the most debilitating.

As highlighted by the researchers, long COVID strikes young and middle-aged adults during their most productive years, inflicting substantial harm on global workforces, overall productivity, and innovative capacities everywhere.

U.S. patients in this analysis uniformly described the heaviest loads of neurological and psychological symptoms, which profoundly impaired their daily life quality and professional capabilities, noted Koralnik. He also co-directs the Comprehensive COVID Center at Northwestern Medicine and oversees the global neurology initiative at the Havey Institute for Global Health at Feinberg.

Implications for Future Research and Care

The investigators stress that these outcomes underscore the critical need for screening and diagnostic methods tailored to cultural contexts in managing long COVID. They advocate for healthcare infrastructures equipped to deliver sustained care and monitoring over extended periods.

Leveraging these insights, Koralnik and his collaborators across borders are presently evaluating cognitive rehabilitation therapies aimed at alleviating long COVID-related brain fog in Colombia and Nigeria. These trials employ identical protocols to those refined for patients at Chicago's Shirley Ryan AbilityLab.

The publication bears the title A cross-continental comparative analysis of the neurological manifestations of Long COVID.